Sol Barer

Sol Barer, Ph.D. is a founder and chairman of the board of directors of Centrexion Therapeutics. Sol brings more than 30 years of experience in the biotechnology industry. He is the managing partner of SJBarer Consulting and was a founder of Celgene, a global biopharmaceutical company. From 1987 to 2011, Sol led Celgene in various executive roles, including president, COO and CEO. He also served as the executive chairman and chairman of the company’s board of directors. Sol currently serves as chairman of the board of Teva Pharmaceutricals, Edge Therapeutics, Inc. and Aevi Genomic Medicine. He is also lead director of Contrafect Corp. He is also the Founding Chair of the Hackensack Meridian Health Center for Discovery & Innovation and is associated with Barer & Son LLC which invests in early stage breakthrough biotechnology companies. Sol holds a B.S. from Brooklyn College and a Ph.D. in organic chemistry from Rutgers University.